Appropriates $2.5 million to DOBI to reimburse joint insurance funds for COVID-19 surveillance testing.
This bill appropriates $2.5 million from the state General Fund to the Department of Banking and Insurance (DOBI) to reimburse joint insurance funds for covering COVID-19 surveillance testing costs. It directly affects insurance plans providing group health coverage to "covered workers" (defined in Governor Murphy's executive orders), specifically for weekly testing of unvaccinated, asymptomatic employees in healthcare and high-risk settings from August 2021 to August 2022. The reimbursement covers costs incurred by insurance funds that voluntarily provided this testing despite federal guidance not requiring it. The bill establishes a process for funds to request reimbursement through DOBI and clarifies that "surveillance testing" refers to routine screening to identify asymptomatic cases, distinct from required medical testing.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026
Last action Jan 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Carol Murphy
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 970
Scope: NJ
Hi! I can help you understand A 970. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline